PIK3CA and prostate adenocarcinoma: Multiscale modeling, including the role that single cell models of ErbB receptor-mediated Ras-MAPK and PI3K/AKT signaling, has been used to study the response to a drug-reposition treatment in prostate adenocarcinoma (162).